Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Therapy-related leukemia: clinical characteristics and analysis of new molecular risk factors in 96 adult patients.

Leukemia - 1 Nov 2005

Rund D, Krichevsky S, Bar-Cohen S, Goldschmidt N, Kedmi M, Malik E, Gural A, Shafran-Tikva S, Ben-Neriah S, Ben-Yehuda D

Abstract excerpt

Therapy-related leukemia or myelodysplasia (t-leuk/MDS) is a serious problem that is increasing in frequency. We studied the clinical characteristics of 96 patients (pts) with a mean age of 48 years, and analyzed the molecular parameters that could predispose to t-leuk/MDS. Hematological malignancies were the most common primary (53%), followed by breast and ovarian cancer (30% combined). The mean latency until...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cytochrome P-450 CYP3A
Share to Cytochrome P-450 Enzyme System

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genes, MDR

Share to Leukemia

Share to MutL Protein Homolog 1

Share to Myelodysplastic Syndromes

Share to Neoplasms, Second Primary

Share to Ribosomal Protein S6 Kinases, 90-kDa

Source

Identifiers

PMID: 16167058
DOI: 10.1038/sj.leu.2403947

Genes

FLT3
MLH1
MSH2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Therapy-related leukemia: clinical characteristics and analysis of new molecular risk factors in 96 adult patients.PMID 16167058Read ↗

Treatment-related myelodysplastic syndrome: molecular characteristics and therapy.Semantic proximity Read ↗

Therapy-related myelodysplasia and acute myeloid leukemia.Semantic proximity Read ↗

Therapy-related myeloid leukemia.Semantic proximity Read ↗

Epigenetic changes in therapy-related MDS/AMLSemantic proximity Read ↗

Epidemiology of myelodysplastic syndromes.Semantic proximity Read ↗

Profile of polymorphisms of drug-metabolising enzymes and the risk of therapy-related leukaemia.Semantic proximity Read ↗

Therapy-related myeloid neoplasms: pathobiology and clinical characteristics.Semantic proximity Read ↗

PROGNOSIS AND THERAPY WHEN ACUTE PROMYELOCYTIC LEUKEMIA AND OTHER “GOOD RISK” ACUTE MYELOID LEUKEMIAS OCCUR AS A THERAPY-RELATED MYELOID NEOPLASMSemantic proximity Read ↗

Influence of DNA damage and repair upon the risk of treatment related leukemia.Semantic proximity Read ↗

Genetic pathways in the pathogenesis of therapy-related myelodysplasia and acute myeloid leukemia.Semantic proximity Read ↗

Therapy Related Leukemias: Susceptibility, Prevention and TreatmentSemantic proximity Read ↗

Leukaemogenesis, gene interplay, and the role of the haemopoietic environment.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.